CDKN2A and neoplasm: CDKN2A (cyclin-dependent kinase inhibitor 2A) is a cyclin-dependent kinase inhibitor gene that encodes the p16 gene involved in a series of cell cycle pathways, such as inhibiting cell proliferation, promoting tumor cell apoptosis, and increasing tumor cell chemotherapy sensitivity by causing cell cycle arrest in the G1 phase.